- Home
- STOK vs THQ Comparison
STOK vs THQ Comparison
Compare STOK & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- THQ
- Stock Information
- Founded
- STOK 2014
- THQ 2014
- Country
- STOK United States
- THQ United States
- Employees
- STOK N/A
- THQ N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- THQ Finance Companies
- Sector
- STOK Health Care
- THQ Finance
- Exchange
- STOK Nasdaq
- THQ Nasdaq
- Market Cap
- STOK 721.4M
- THQ 780.4M
- IPO Year
- STOK 2019
- THQ N/A
- Fundamental
- Price
- STOK $9.36
- THQ $19.92
- Analyst Decision
- STOK Strong Buy
- THQ
- Analyst Count
- STOK 8
- THQ 0
- Target Price
- STOK $21.83
- THQ N/A
- AVG Volume (30 Days)
- STOK 933.4K
- THQ 158.9K
- Earning Date
- STOK 11-05-2024
- THQ 01-01-0001
- Dividend Yield
- STOK N/A
- THQ 7.53%
- EPS Growth
- STOK N/A
- THQ N/A
- EPS
- STOK N/A
- THQ N/A
- Revenue
- STOK $16,742,999.00
- THQ N/A
- Revenue This Year
- STOK $105.42
- THQ N/A
- Revenue Next Year
- STOK N/A
- THQ N/A
- P/E Ratio
- STOK N/A
- THQ N/A
- Revenue Growth
- STOK 81.08
- THQ N/A
- 52 Week Low
- STOK $4.09
- THQ $15.29
- 52 Week High
- STOK $17.58
- THQ $20.38
- Technical
- Relative Strength Index (RSI)
- STOK 36.22
- THQ 60.02
- Support Level
- STOK $8.42
- THQ $18.59
- Resistance Level
- STOK $9.77
- THQ $19.14
- Average True Range (ATR)
- STOK 0.66
- THQ 0.29
- MACD
- STOK -0.09
- THQ 0.17
- Stochastic Oscillator
- STOK 28.40
- THQ 89.26
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.